Kojiro Ohba
Papers
1
Total Citations
8
H-Index
1
About
Dr. Kojiro Ohba is a leading urological oncologist whose research focuses on optimizing surgical management for high-risk prostate cancer, particularly through the nuanced application of pelvic lymph node dissection (PLND). His most impactful work, a 2024 multi-institutional study, directly addresses the long-standing debate over the therapeutic benefit of extended PLND (ePLND) versus no dissection in patients with high- or very high-risk disease. By demonstrating that ePLND significantly reduces biochemical recurrence (BCR) rates, Dr. Ohba provides compelling evidence that PLND offers more than just staging information—it confers a tangible oncological advantage. This finding challenges existing clinical equipoise and has immediate implications for surgical decision-making. With 8 citations in its first year, this study is rapidly shaping practice patterns. Dr. Ohba’s contributions are pivotal for clinicians seeking to balance the morbidity of extended dissection against improved cancer control, cementing his role as a key voice in evidence-based urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1